- 6.0CiteScore
- 22 daysTime to First Decision
Non-communicable Diseases, Big Data and Artificial Intelligence
This special issue belongs to the section “Methodology, Drug and Device Discovery“.
Special Issue Information
Dear Colleagues,
The 2030 Agenda for Sustainable Development adopted by the United Nations in 2015 recognized non-communicable diseases (NCDs) as a major public health challenge. NCDs are usually multifactorial diseases influenced by both genetic and environmental factors, which makes them difficult to prevent and treat effectively. Medical and health big data consisting of lifestyle, clinical, and biological data provide an almost unlimited amount of information about diseases, far exceeding the human ability to make sense of it. Artificial intelligence (AI) offers the potential to analyze large and complex datasets in order to improve predicative, preventive, and personalized medicine (3P medicine). This Special Issue plans to give an overview of the most recent advances in the field of AI and their application potential in 3P medicine.
Potential topics include, but are not limited to:
- Cutting edge advances in AI in terms of medical and health big data.
- Application of AI in risk stratifying of diseases.
- Risk factor screening using AI.
- Application of AI in diagnosis.
- Application of AI in prognosis.
- Evaluation of the therapeutic effects of using AI.
Prof. Dr. Youxin Wang
Dr. Ming Feng
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Non-Communicable Diseases
- Big data
- 3P Medicine
- Precision Medicine
- Artificial Intelligence
- Machine Learning
- Diagnosis
- Prognosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Published Papers
Get Alerted
Add your email address to receive forthcoming issues of this journal.
